Cargando…
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
Prognostic markers help to stratify patients for treatment by identifying patients with different risks of outcome (e.g. recurrence of disease), and are important tools in the management of cancer and many other diseases. Systematic review and meta-analytical approaches to identifying the most valua...
Autores principales: | Riley, R D, Abrams, K R, Sutton, A J, Lambert, P C, Jones, D R, Heney, D, Burchill, S A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747576/ https://www.ncbi.nlm.nih.gov/pubmed/12698183 http://dx.doi.org/10.1038/sj.bjc.6600886 |
Ejemplares similares
-
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond
por: Riley, R D, et al.
Publicado: (2009) -
Current guidelines for high-density lipoprotein cholesterol in therapy and future directions
por: Subedi, Bishnu H, et al.
Publicado: (2014) -
A review of the quantitative effectiveness evidence synthesis methods used in public health intervention guidelines
por: Smith, Ellesha A., et al.
Publicado: (2021) -
Bivariate random-effects meta-analysis and the estimation of between-study correlation
por: Riley, Richard D, et al.
Publicado: (2007) -
WFSBP Treatment Guidelines and the problem of evidence grading
por: Möller, Hans Jürgen
Publicado: (2010)